Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pharyngeal Neoplasms × Resistance Training × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pharyngeal Neoplasms 1 Neoplasms 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 2 Cetuximab 2 zimberelimab 1 temsirolimus 1 Valproic Acid 1 Sirolimus 1 Resistance Training 1 Radiotherapy 1 Radiation 1 Nutritional Status 1 Immunoglobulin G 1 Etoposide 1 Disulfides 1 Cyclophosphamide 1 Bortezomib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01332682 2023-10-18

Resistance Training and Physical Functioning in Head and Neck Cancer Patients

University of Alabama at Birmingham

Phase 1 Completed

Head and Neck Neoplasms, Laryngeal Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡